Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00440492 · ClinicalTrials.gov registry record · Phase 1

Study To Evaluate The Pharmacokinetic Interaction Between PLA-695 And Methotrexate In Adults With Rheumatoid Arthritis

A Phase 1 study of Arthritis, Rheumatoid, sponsored by Wyeth is now a wholly owned subsidiary of Pfizer.

Completed
Registry status
Phase 1
Development phase
9
Study locations

NCT00440492 is a Phase 1 study of Arthritis, Rheumatoid that has completed, run by Wyeth is now a wholly owned subsidiary of Pfizer. The trial reports 9 study locations across 7 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00440492, a Phase 1 study of Arthritis, Rheumatoid, has completed, sponsored by Wyeth is now a wholly owned subsidiary of Pfizer.

COMPLETED
Registry status
Phase 1
Development phase
9
Study locations

Study Summary

The purpose of this study is to determine if PLA-695 changes the blood concentrations of methotrexate when administered together.

Conditions Studied

Arthritis, Rheumatoid

Interventions

  • DRUG PLA-695

Study Locations (9)

California

  • - Los Angeles
  • - Palo Alto

New York

  • - Lake Success
  • - Rochester

North Carolina

  • - Charlotte

Ohio

  • - Columbus

British Columbia

  • - Vancouver

Ontario

  • - Mississauga

Quebec

  • - Montreal

Trial Details

FieldValue
Start Date 2006-12
Est. Completion 2007-11
Phase Phase 1

Sponsor

Wyeth is now a wholly owned subsidiary of Pfizer

167 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00440492

The ClinicalTrials.gov registry entry for NCT00440492 describes a study currently listed as completed, categorized as Phase 1. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Wyeth is now a wholly owned subsidiary of Pfizer, which has 167 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Arthritis, Rheumatoid appearing as the primary indexed condition, and to 1 intervention - of which PLA-695 is the first listed.

NCT00440492 reports 9 study locations spanning 7 distinct geographic areas - top geographies include California, New York, North Carolina.

Frequently Asked Questions

What is clinical trial NCT00440492 about?

NCT00440492 is a clinical study titled "Study To Evaluate The Pharmacokinetic Interaction Between PLA-695 And Methotrexate In Adults With Rheumatoid Arthritis". The purpose of this study is to determine if PLA-695 changes the blood concentrations of methotrexate when administered together.

What is the current status of trial NCT00440492?

This trial is currently completed. It is a Phase 1 study. The study started on 2006-12. Estimated completion is 2007-11.

What conditions does trial NCT00440492 study?

This clinical trial studies the following conditions: Arthritis, Rheumatoid.

What interventions are being tested in trial NCT00440492?

The interventions under investigation include: PLA-695 (DRUG).

Who is sponsoring clinical trial NCT00440492?

This trial is sponsored by Wyeth is now a wholly owned subsidiary of Pfizer, which has 167 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00440492 being conducted?

This trial has 9 study locations across California, New York, North Carolina, Ohio, British Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Arthritis, Rheumatoid

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Arthritis, Rheumatoid

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.